TANSHI MEHROTRA

About

PhD graduate from BRIC–Translational Health Science and Technology Institute (THSTI) with expertise in antimicrobial resistance (AMR), microbial genomics, molecular epidemiology, and translational diagnostics. My research focuses on multidrug-resistant Gram-negative ESKAPE pathogens, AMR evolution, comparative genomics, whole genome sequencing, and rapid molecular diagnostics for clinically relevant and public health applications. I am particularly interested in understanding resistance dissemination through mobile genetic elements and applying genomics-driven approaches to strengthen AMR surveillance and development of clinically deployable diagnostic solutions.

Employment

• Translational Health Science and Technology Institute PhD student
  2021 - Present

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (6)

• A decade of antimicrobial resistance in Vibrio spp.: genomic and functional insights
  Microbiology Spectrum 2026 DOI: 10.1128/spectrum.02162-25
  +Save
• Antimicrobial resistance heterogeneity among multidrug-resistant Gram-negative pathogens: Phenotypic, genotypic, and proteomic analysis
  Proceedings of the National Academy of Sciences 2023 DOI: 10.1073/pnas.2305465120
  +Save
• Region-specific genomic signatures of multidrug-resistant Helicobacter pylori isolated from East and South India
  Gene 2022 DOI: 10.1016/j.gene.2022.146857
  +Save
• Hepatic drug metabolism and gut microbiome
  Progress in Molecular Biology and Translational Science 2022 DOI: 10.1016/bs.pmbts.2022.07.005
  +Save
• Antimicrobial resistance and virulence in Helicobacter pylori: Genomic insights
  Genomics 2021 DOI: 10.1016/j.ygeno.2021.10.002
  +Save
• Vaccines for neglected, emerging and re-emerging diseases
  Seminars in Immunology 2020 DOI: 10.1016/j.smim.2020.101423
  +Save